Variant report
Variant | nsv969942 |
---|---|
Chromosome Location | chr5:105154948-105169094 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs541010253 | chr5:105162038-105162039 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs564795687 | chr5:105162059-105162060 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs566556879 | chr5:105162088-105162089 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs527411078 | chr5:105162115-105162116 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs533662390 | chr5:105162143-105162144 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs550440313 | chr5:105162178-105162179 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs563867483 | chr5:105162210-105162211 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs549596607 | chr5:105162261-105162262 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs567917396 | chr5:105162273-105162274 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs529373714 | chr5:105162296-105162297 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs567804297 | chr5:105162317-105162318 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs62366669 | chr5:105162440-105162441 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs76691323 | chr5:105162449-105162450 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs565956382 | chr5:105162480-105162481 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs76056026 | chr5:105162496-105162497 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs139202543 | chr5:105162575-105162576 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs574231692 | chr5:105164002-105164003 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs543254370 | chr5:105164070-105164071 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs188216473 | chr5:105164078-105164079 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs559683564 | chr5:105164108-105164109 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs67869343 | chr5:105164119-105164120 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs192768101 | chr5:105164170-105164171 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs552489758 | chr5:105164211-105164212 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs72779337 | chr5:105164256-105164257 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs531500729 | chr5:105164274-105164275 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs373310229 | chr5:105164357-105164358 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs184416792 | chr5:105164409-105164410 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs80177366 | chr5:105164416-105164417 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs189694938 | chr5:105164474-105164475 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs569979639 | chr5:105164577-105164578 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs529164877 | chr5:105164598-105164599 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs286712 | chr5:105164601-105164602 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs565834355 | chr5:105164602-105164603 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs567740502 | chr5:105164627-105164628 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs367976283 | chr5:105164634-105164635 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs534731142 | chr5:105164667-105164668 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs181296347 | chr5:105164901-105164902 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs185865800 | chr5:105164916-105164917 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs537080422 | chr5:105164952-105164953 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs373517157 | chr5:105165004-105165005 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs556681870 | chr5:105165014-105165015 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs74966732 | chr5:105165107-105165108 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs560237728 | chr5:105165115-105165116 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs189097080 | chr5:105165123-105165124 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs573064503 | chr5:105165155-105165156 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs545179000 | chr5:105165171-105165172 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs181830891 | chr5:105165172-105165173 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs142127598 | chr5:105165181-105165182 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs370879753 | chr5:105165223-105165224 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs530907727 | chr5:105165292-105165293 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Colorectal cancer | 16774939 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Neurocytoma | 17123091 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 16608533 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung cancer | 16773561 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17142309 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:105162000-105162200 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr5:105162000-105162400 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
3 | chr5:105162000-105162400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr5:105162000-105162600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
5 | chr5:105162000-105162600 | Enhancers | Adipose Nuclei | Adipose |
6 | chr5:105162200-105162600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
7 | chr5:105162200-105162600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
8 | chr5:105164000-105172200 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
9 | chr5:105167800-105168600 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
10 | chr5:105167800-105168600 | Enhancers | Ovary | ovary |